Options
ARAOS BRALIC, RAFAEL IGNACIO
Preferred name
ARAOS BRALIC, RAFAEL IGNACIO
Main Affiliation
Email
rafaelaraos@udd.cl
ORCID
Scopus Author ID
34976138500
Now showing
1 - 10 of 20
-
PublicationAntibiotic Consumption During the Coronavirus Disease 2019 Pandemic and Emergence of Carbapenemase-Producing Klebsiella pneumoniae Lineages Among Inpatients in a Chilean Hospital: A Time-Series Study and Phylogenomic Analysis( 2023)
Scopus© Citations 7 30 -
PublicationMulti-country cross-sectional study of colonization with multidrug-resistant organisms: protocol and methods for the Antibiotic Resistance in Communities and Hospitals (ARCH) studies( 2021)
Scopus© Citations 15 3 -
PublicationDynamics of the MRSA Population in a Chilean Hospital: a Phylogenomic Analysis (2000–2016)( 2023)
Scopus© Citations 2 28 -
PublicationClinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosa( 2020)
Scopus© Citations 38 4 1 -
PublicationMulticenter Evaluation of Ceftolozane/Tazobactam for Serious Infections Caused by Carbapenem-Resistant Pseudomonas aeruginosa( 2017)
Scopus© Citations 112 4 -
PublicationNeuro-retinitis asociada a enfermedad por arañazo de gato: Presentación de dos casos y revisión de la literatura( 2010)
9 -
PublicationFirst wave of SARS-CoV-2 in Santiago Chile: Seroprevalence, asymptomatic infection and infection fatality rate( 2022)
17 -
PublicationTransmission of gram-negative antibiotic-resistant bacteria following differing exposure to antibiotic-resistance reservoirs in a rural community: a modelling study for bloodstream infections( 2022)
Scopus© Citations 2 13 -
PublicationIsolation of Ciprofloxacin and Ceftazidime-Resistant Enterobacterales From Vegetables and River Water Is Strongly Associated With the Season and the Sample Type( 2021)
Scopus© Citations 15 8 -
PublicationHigher MICs (> 2 mg/L) Predict 30-Day Mortality in Patients With Lower Respiratory Tract Infections Caused by Multidrug- and Extensively Drug-Resistant Pseudomonas aeruginosa Treated With Ceftolozane/Tazobactam( 2019)
Scopus© Citations 22 3